Jahn Thomas, Hubmann Werner, Karr Marcus, Mohr Fritz, Schlenker Regine, Heidenreich Thomas, Cohen Rudolf, Schröder Johannes
Department of Psychiatry and Psychotherapy, Technical University Munich, Germany.
Psychiatry Res. 2006 Jun 15;142(2-3):191-9. doi: 10.1016/j.psychres.2002.12.003. Epub 2006 May 2.
Motoric neurological soft signs (NSS) were investigated by means of the Brief Motor Scale (BMS) in 82 inpatients with DSM-III-R schizophrenic psychoses. To address potential fluctuations of psychopathological symptoms and extrapyramidal side effects, patients were examined in the subacute state, twice at an interval of 14 days on the average. NSS were significantly correlated with severity of illness, lower social functioning, and negative symptoms. Modest, but significant correlations were found between NSS and extrapyramidal side effects as assessed on the Simpson-Angus Scale. Neither the neuroleptic dose prescribed to the patient, nor scores for tardive dyskinesia and akathisia were significantly correlated with NSS. Moreover, NSS scores did not significantly differ between patients receiving clozapine and conventional neuroleptics. Patients in whom psychopathological symptoms remained stable or improved over the clinical course showed a significant reduction of NSS scores. This finding did not apply to those patients in whom psychopathological symptoms deteriorated. Our findings demonstrate that NSS in schizophrenic psychoses are relatively independent of neuroleptic side effects, but they are associated with the severity and persistence of psychopathological symptoms and with poor social functioning.
采用简易运动量表(BMS)对82例符合DSM - III - R精神分裂症性精神病的住院患者进行运动性神经软体征(NSS)调查。为了应对精神病理症状和锥体外系副作用的潜在波动,在亚急性期对患者进行检查,平均间隔14天检查两次。NSS与疾病严重程度、较低的社会功能及阴性症状显著相关。在辛普森 - 安格斯量表评估中,NSS与锥体外系副作用之间存在适度但显著的相关性。患者所服用的抗精神病药物剂量、迟发性运动障碍和静坐不能评分与NSS均无显著相关性。此外,接受氯氮平治疗的患者与接受传统抗精神病药物治疗的患者之间,NSS评分无显著差异。在临床病程中精神病理症状保持稳定或改善的患者,其NSS评分显著降低。这一发现不适用于精神病理症状恶化的患者。我们的研究结果表明,精神分裂症性精神病中的NSS相对独立于抗精神病药物副作用,但与精神病理症状的严重程度和持续性以及不良社会功能相关。